Outer Web | Explore

Explore >> Select a destination

You are here		www.theatlantic.com Pfizer Vaccine Full Approval: Why the FDA Took So Long - The Atlantic
\|	\|	donshafi911health.wordpress.com Peter Doshi: Pfizer and Moderna's "95% effective" vaccines-we need more details and the raw data - The BMJ - donshafi9??1??1??	2.0 parsecs away Travel
\|	\|	Peter Doshi: Pfizer and Moderna's "95% effective" vaccines-we need more details and the raw data January 4, 2021 Five weeks ago, when Iraised questionsabout the results of Pfizer's and Moderna's covid-19 vaccine trials, all that was in the public domain were thestudy protocolsand afewpressreleases. Today, twojournalpublicationsand around 400 pages of summary data are available in...	2.0 parsecs away Travel
\|	\|	www.fda.gov FDA Authorizes Updated Novavax COVID-19 Vaccine Formulated to Better Protect Against Currently Circulating Variants \| FDA	2.2 parsecs away Travel
\|	\|	The FDA amended the emergency use authorization of the Novavax COVID-19 Vaccine, Adjuvanted for use in individuals 12 years of age and older to include the 2023-2024 formula. The updated vaccine addresses currently circulating variants to provide better protection against serious consequences of COV	2.2 parsecs away Travel
\|	\|	archive.discoversociety.org All for Vaccination? Vaccination for All? \| Discover Society	3.7 parsecs away Travel
\|	\|	Measured - Factual - Critical	3.7 parsecs away Travel
\|	\|	www.plengegen.com The inconvenient path of precision medicine in drug development - Plenge Gen @rplengePlenge Gen @rplenge	25.5 parsecs away Travel
\|		Discovery Research \| Better Health	25.5 parsecs away Travel